{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:25:18Z","timestamp":1794493518485,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health Systems Research Institute, Thailand","award":["HSRI 65-051 \/ R016541048"],"award-info":[{"award-number":["HSRI 65-051 \/ R016541048"]}]},{"name":"Health Systems Research Institute, Thailand","award":["HSRI 65-051 \/ R016541048"],"award-info":[{"award-number":["HSRI 65-051 \/ R016541048"]}]},{"name":"Health Systems Research Institute, Thailand","award":["HSRI 65-051 \/ R016541048"],"award-info":[{"award-number":["HSRI 65-051 \/ R016541048"]}]},{"name":"Health Systems Research Institute, Thailand","award":["HSRI 65-051 \/ R016541048"],"award-info":[{"award-number":["HSRI 65-051 \/ R016541048"]}]},{"name":"Health Systems Research Institute, Thailand","award":["HSRI 65-051 \/ R016541048"],"award-info":[{"award-number":["HSRI 65-051 \/ R016541048"]}]},{"name":"Health Systems Research Institute, Thailand","award":["HSRI 65-051 \/ R016541048"],"award-info":[{"award-number":["HSRI 65-051 \/ R016541048"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Cervical cancer ranks as the third most prevalent cancer among women in Thailand. However, the effectiveness of cervical cancer screening programs is limited by several factors that impede the screening rate. The utilization of self-collected samples for screening purposes has the potential to alleviate barriers to screening in Thai women. This study assessed the cost-utility and budget impact of implementing cervical cancer screening using self-collected samples for human papillomavirus (HPV) deoxyribonucleic acid (DNA) testing in Thailand.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>We employed a decision tree integrated with a Markov model to estimate the lifetime costs and health benefits associated with the cervical cancer screening program for women aged 25\u201365. The analysis was conducted from a societal perspective. Four screening policy options were compared: (1) additional self-collected samples for HPV DNA testing, (2) clinician-collected samples for HPV DNA testing only, (3) clinician-collected samples for cytology test (i.e., status quo), and (4) no screening. The model inputs were based on unvaccinated women. The screening strategies and management in those with positive results were assumed followed to the Thai clinical practice guideline. Costs were reported in 2022 Thai baht. Sensitivity analyses were conducted. The ten-year budget impacts of the additional self-collected samples for HPV DNA testing were calculated from a payer perspective.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All screening policies were cost-saving compared to no screening. When comparing the additional self-collected samples for HPV DNA testing with the clinician-collected samples policy, it emerged as the dominant strategy. The incremental benefit in cervical cancer prevention achieved by incorporating self-collected samples for screening was observed at any additional screening rate that could be achieved through their use. Sensitivity analyses yielded consistently favorable results for the screening policies. The average annual budget impact of the additional self-collected samples for screening policy amounted to 681\u00a0million Thai baht. This budget allocation could facilitate cervical cancer screening for over 10\u00a0million women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>An addition of self-collected samples for HPV DNA testing into the cervical cancer screening program is cost-saving. The benefits of this screening policy outweigh the associated incremental costs. Policymakers should consider this evidence during the policy optimization process.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-023-17358-0","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T18:01:41Z","timestamp":1701712901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand"],"prefix":"10.1186","volume":"23","author":[{"given":"Chayanis","family":"Kositamongkol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukrit","family":"Kanchanasurakit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euarat","family":"Mepramoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattarawalai","family":"Talungchit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattama","family":"Chaopotong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirati","family":"Kengkla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanet","family":"Chaisathaphol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surasak","family":"Saokaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pochamana","family":"Phisalprapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"issue":"23","key":"17358_CR1","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1002\/cncr.34487","volume":"128","author":"BJ Rimel","year":"2022","unstructured":"Rimel BJ, Kunos CA, Macioce N, Temkin SM. Current gaps and opportunities in screening, prevention, and treatment of Cervical cancer. Cancer. 2022;128(23):4063\u201373.","journal-title":"Cancer"},{"key":"17358_CR2","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. 2 ed. Geneva: World Health Organization; 2021."},{"key":"17358_CR3","unstructured":"World Health Organization. The Global Cancer Observatory: Thailand. The Global Cancer Observatory. 2020."},{"issue":"3","key":"17358_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"17358_CR5","doi-asserted-by":"publisher","first-page":"e0245894","DOI":"10.1371\/journal.pone.0245894","volume":"16","author":"W Termrungruanglert","year":"2021","unstructured":"Termrungruanglert W, Khemapech N, Vasuratna A, Havanond P, Deebukkham P, Kulkarni AS, et al. The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand. PLoS ONE. 2021;16(2):e0245894.","journal-title":"PLoS ONE"},{"issue":"1","key":"17358_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.31557\/APJCP.2021.22.1.25","volume":"22","author":"P Ploysawang","year":"2021","unstructured":"Ploysawang P, Rojanamatin J, Prapakorn S, Jamsri P, Pangmuang P, Seeda K, et al. National Cervical Cancer Screening in Thailand. Asian Pac J Cancer Prev. 2021;22(1):25\u201330.","journal-title":"Asian Pac J Cancer Prev"},{"key":"17358_CR7","doi-asserted-by":"publisher","first-page":"e2200359","DOI":"10.1200\/GO.22.00359","volume":"9","author":"EJ Akoto","year":"2023","unstructured":"Akoto EJ, Allsop MJ. Factors influencing the experience of breast and Cervical Cancer screening among women in low- and Middle-Income countries: a systematic review. JCO Glob Oncol. 2023;9:e2200359.","journal-title":"JCO Glob Oncol"},{"issue":"11","key":"17358_CR8","doi-asserted-by":"publisher","first-page":"e031957","DOI":"10.1136\/bmjopen-2019-031957","volume":"9","author":"A Gottschlich","year":"2019","unstructured":"Gottschlich A, Nuntadusit T, Zarins KR, Hada M, Chooson N, Bilheem S, et al. Barriers to Cervical cancer screening and acceptability of HPV self-testing: a cross-sectional comparison between ethnic groups in Southern Thailand. BMJ Open. 2019;9(11):e031957.","journal-title":"BMJ Open"},{"issue":"2","key":"17358_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ygyno.2022.06.012","volume":"166","author":"F Sy","year":"2022","unstructured":"Sy F, Greuel M, Winkler V, Bussmann H, B\u00e4rnighausen T, Deckert A. Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: a systematic review and meta-analysis. Gynecol Oncol. 2022;166(2):358\u201368.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"17358_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","volume":"15","author":"M Arbyn","year":"2014","unstructured":"Arbyn M, Verdoodt F, Snijders PJF, Verhoef VMJ, Suonio E, Dillner L, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014;15(2):172\u201383.","journal-title":"Lancet Oncol"},{"issue":"10","key":"17358_CR11","first-page":"817","volume":"29","author":"DE Stewart","year":"2007","unstructured":"Stewart DE, Gagliardi A, Johnston M, Howlett R, Barata P, Lewis N, et al. Self-collected samples for testing of oncogenic human papillomavirus: a systematic review. J Obstet Gynecol Canada: JOGC = J D\u2019obstetrique et gynecologie du Can : JOGC. 2007;29(10):817\u201328.","journal-title":"J Obstet Gynecol Canada: JOGC = J D\u2019obstetrique et gynecologie du Can : JOGC"},{"key":"17358_CR12","unstructured":"The Royal Thai College of Obstetricians and Gynaecologists. Cerv Cancer Screen. 2021:1\u201311 pp.]."},{"issue":"5","key":"17358_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3322\/caac.21628","volume":"70","author":"ETH Fontham","year":"2020","unstructured":"Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020;70(5):321\u201346.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"17358_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40273-021-01112-8","volume":"40","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated Health Economic evaluation reporting standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. Pharmaco Economics. 2022;40(6):601\u20139.","journal-title":"Pharmaco Economics"},{"key":"17358_CR15","unstructured":"Guideline Development Working Group. Health Technology Assessment Guideline for Thailand. 3 ed. 2019. Feb 2021."},{"key":"17358_CR16","doi-asserted-by":"publisher","first-page":"100332","DOI":"10.1016\/j.lanepe.2022.100332","volume":"14","author":"M Arbyn","year":"2022","unstructured":"Arbyn M, Latsuzbaia A, Castle PE, Sahasrabuddhe VV, Broeck DV. HPV testing of self-samples: influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer. Lancet Reg Health Eur. 2022;14:100332.","journal-title":"Lancet Reg Health Eur"},{"key":"17358_CR17","doi-asserted-by":"publisher","first-page":"100235","DOI":"10.1016\/j.lanepe.2021.100235","volume":"11","author":"F Inturrisi","year":"2021","unstructured":"Inturrisi F, Aitken CA, Melchers WJG, van den Brule AJC, Molijn A, Hinrichs JWJ, et al. Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: an observational study. Lancet Reg Health Eur. 2021;11:100235.","journal-title":"Lancet Reg Health Eur"},{"issue":"7","key":"17358_CR18","first-page":"3147","volume":"17","author":"S Tangjitgamol","year":"2016","unstructured":"Tangjitgamol S, Kantathavorn N, Kittisiam T, Chaowawanit W, Phoolcharoen N, Manusirivithaya S, et al. Prevalence and Associated factors of abnormal cervical cytology and HighRisk HPV DNA among Bangkok Metropolitan women. Asian Pac J Cancer Prev. 2016;17(7):3147\u201353.","journal-title":"Asian Pac J Cancer Prev"},{"key":"17358_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.gore.2017.06.003","volume":"21","author":"N Phoolcharoen","year":"2017","unstructured":"Phoolcharoen N, Kantathavorn N, Sricharunrat T, Saeloo S, Krongthong W. A population-based study of cervical cytology findings and human papillomavirus Infection in a suburban area of Thailand. Gynecol Oncol Rep. 2017;21:73\u20137.","journal-title":"Gynecol Oncol Rep"},{"issue":"2","key":"17358_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1471-0528.2011.02974.x","volume":"119","author":"M Sharma","year":"2012","unstructured":"Sharma M, Ortendahl J, van der Ham E, Sy S, Kim JJ. Cost-effectiveness of human papillomavirus vaccination and Cervical cancer screening in Thailand. BJOG. 2012;119(2):166\u201376.","journal-title":"BJOG"},{"issue":"9","key":"17358_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2165\/11586560-000000000-00000","volume":"29","author":"N Praditsitthikorn","year":"2011","unstructured":"Praditsitthikorn N, Teerawattananon Y, Tantivess S, Limwattananon S, Riewpaiboon A, Chichareon S, et al. Economic evaluation of policy options for prevention and control of Cervical cancer in Thailand. PharmacoEconomics. 2011;29(9):781\u2013806.","journal-title":"PharmacoEconomics"},{"issue":"8","key":"17358_CR22","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s12094-022-02808-9","volume":"24","author":"NR Gomez-Hidalgo","year":"2022","unstructured":"Gomez-Hidalgo NR, Acosta U, Rodriguez TG, Mico S, Verges R, Conesa VB, et al. Adjuvant therapy in early-stage Cervical cancer after radical hysterectomy: are we overtreating our patients? A meta-analysis. Clin Transl Oncol. 2022;24(8):1605\u201314.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"17358_CR23","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1038\/s41598-018-24882-2","volume":"8","author":"C Bekos","year":"2018","unstructured":"Bekos C, Schwameis R, Heinze G, Garner M, Grimm C, Joura E, et al. Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis. Sci Rep. 2018;8(1):6383.","journal-title":"Sci Rep"},{"key":"17358_CR24","doi-asserted-by":"publisher","first-page":"k499","DOI":"10.1136\/bmj.k499","volume":"360","author":"K Tainio","year":"2018","unstructured":"Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, Cardenas J, Hernandes, et al. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ. 2018;360:k499.","journal-title":"BMJ"},{"issue":"3","key":"17358_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ygyno.2018.07.005","volume":"150","author":"R Xue","year":"2018","unstructured":"Xue R, Cai X, Xu H, Wu S, Huang H. The efficacy of concurrent weekly carboplatin with radiotherapy in the treatment of Cervical cancer: a meta-analysis. Gynecol Oncol. 2018;150(3):412\u20139.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"17358_CR26","first-page":"CD006469","volume":"10","author":"K Scatchard","year":"2012","unstructured":"Scatchard K, Forrest JL, Flubacher M, Cornes P, Williams C. Chemotherapy for metastatic and recurrent Cervical cancer. Cochrane Database Syst Rev. 2012;10(10):CD006469.","journal-title":"Cochrane Database Syst Rev"},{"key":"17358_CR27","unstructured":"Life tables by country: Thailand. World Health organization. 2019. [Internet]. Available from: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/gho-ghe-life-tables-nmx-age-specific-death-rate-between-ages-x-and-x-plus-n."},{"key":"17358_CR28","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford university press; 2015."},{"key":"17358_CR29","unstructured":"Thailand Consumer Price Index (CPI). 2022 Jul 7, 2022]. Available from: https:\/\/tradingeconomics.com\/thailand\/consumer-price-index-cpi."},{"key":"17358_CR30","unstructured":"Riewpaiboon A. Standard cost lists for health technology assessment. Nonthaburi: Health Intervention and Technology Assessment Program (HITAP); 2011 [Jul 7, 2022]. Available from: https:\/\/costingmenu.hitap.net\/."},{"key":"17358_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision modelling for health economic evaluation","author":"A Briggs","year":"2006","unstructured":"Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: OUP; 2006."},{"issue":"Suppl2","key":"17358_CR32","first-page":"59","volume":"91","author":"S Limwattananon","year":"2008","unstructured":"Limwattananon S. Handling uncertainty of the economic evaluation result: sensitivity analysis. J Med Assoc Thai. 2008;91(Suppl2):59\u2013S65.","journal-title":"J Med Assoc Thai"},{"issue":"Suppl 3","key":"17358_CR33","first-page":"14","volume":"88","author":"S Intharaburan","year":"2005","unstructured":"Intharaburan S, Rakdang I, Tanapat Y. Colposcopic directed biopsy in the management of abnormal pap smear at Phramongkutklao Hospital. J Med Assoc Thai. 2005;88(Suppl 3):14\u20138.","journal-title":"J Med Assoc Thai"},{"key":"17358_CR34","unstructured":"Civil Registration Population Statistics [Internet]. 2022 [cited Jan 1, 2023]. Available from: https:\/\/stat.bora.dopa.go.th\/stat\/statnew\/statMONTH\/statmonth\/#\/displayData."},{"key":"17358_CR35","unstructured":"Ministry of Public Health, National Cancer Institute. Cancer in Thailand Vol X, 2016\u20138. 2021."},{"key":"17358_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.gore.2017.09.007","volume":"22","author":"W Termrungruanglert","year":"2017","unstructured":"Termrungruanglert W, Khemapech N, Tantitamit T, Sangrajrang S, Havanond P, Laowahutanont P. Cost-effectiveness analysis study of HPV testing as a primary Cervical cancer screening in Thailand. Gynecol Oncol Rep. 2017;22:58\u201363.","journal-title":"Gynecol Oncol Rep"},{"key":"17358_CR37","doi-asserted-by":"crossref","unstructured":"Parker SL, Deshmukh AA, Chen B, Lairson DR, Daheri M, Vernon SW et al. Perceived barriers to Cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: results from a telephone survey. Elife. 2023;12.","DOI":"10.7554\/eLife.84664"},{"issue":"1","key":"17358_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ygyno.2019.01.021","volume":"153","author":"P Vassilakos","year":"2019","unstructured":"Vassilakos P, Poncet A, Catarino R, Viviano M, Petignat P, Combescure C. Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in Cervical cancer screening in Switzerland. Gynecol Oncol. 2019;153(1):92\u20139.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"17358_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/ijc.30695","volume":"141","author":"AK Mezei","year":"2017","unstructured":"Mezei AK, Armstrong HL, Pedersen HN, Campos NG, Mitchell SM, Sekikubo M, et al. Cost-effectiveness of Cervical cancer screening methods in low- and middle-income countries: a systematic review. Int J Cancer. 2017;141(3):437\u201346.","journal-title":"Int J Cancer"},{"issue":"8","key":"17358_CR40","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/IGC.0b013e3181a83dd0","volume":"19","author":"LA Trope","year":"2009","unstructured":"Trope LA, Chumworathayi B, Blumenthal PD. Preventing Cervical cancer: stakeholder attitudes toward CareHPV-focused screening programs in Roi-Et Province, Thailand. Int J Gynecol Cancer. 2009;19(8):1432\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"17358_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7196\/SAMJ.2018.v109i1.13278","volume":"109","author":"R Saidu","year":"2018","unstructured":"Saidu R, Moodley J, Tergas A, Momberg M, Boa R, Wright T, et al. South African women\u2019s perspectives on self-sampling for Cervical cancer screening: a mixed-methods study. S Afr Med J. 2018;109(1):47\u201352.","journal-title":"S Afr Med J"},{"key":"17358_CR42","doi-asserted-by":"publisher","first-page":"105931","DOI":"10.1016\/j.ypmed.2019.105931","volume":"131","author":"NG Campos","year":"2020","unstructured":"Campos NG, Alfaro K, Maza M, Sy S, Melendez M, Masch R, et al. The cost-effectiveness of human papillomavirus self-collection among Cervical cancer screening non-attenders in El Salvador. Prev Med. 2020;131:105931.","journal-title":"Prev Med"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-17358-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-17358-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-17358-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T18:02:02Z","timestamp":1701712922000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-17358-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["17358"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-17358-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,4]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted per the Declaration of Helsinki and approved by the Siriraj Institutional Review Board, Faculty of Medicine Siriraj Hospital, Mahidol University (protocol code: 1052\/2564[IRB1]; approval number: Si 046\/2022; approval date: January 13, 2022). The requirement for informed consent had been waived due to retrospective character of the study.The Siriraj Institutional Review Board affirmed that the aforementioned research involved retrospective review on Siriraj Hospital database. With the retrospective study design, requirement for informed consent had been waived. (Reference: Standard Operating Procedures Topic 5.3, version 8.1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2413"}}